TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer

CONCLUSION: TrkB/BDNF signaling may be a new therapeutic target for PDAC. Therapies targeting TrkB/BDNF signaling may be a conclusive cancer therapy for refractory solid cancer.PMID:34281873 | DOI:10.21873/anticanres.15205
Source: Cell Research - Category: Cytology Authors: Source Type: research